European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Clinical genetics<br />
A 29 years old man with problem in walking and diagnosis of ataxia<br />
which was began from 5 years before with alternating dizziness, ataxia,<br />
tremor, vision disturbance and chocking.<br />
Normal mental state, cranial nerve, autonomic function, motor exam<br />
in inspection with mild hypotonia and normal sensory were seen in<br />
examination.<br />
In ophthalmologic exam all was normal but nystagmous with low speed<br />
and range.<br />
All cerebellar exam was disturbed including, ataxic gait, scanning<br />
speech, intention tremor, hyperreflexia, dysphagia, dysmetria and dysdiadokinesis.<br />
Brain MRI was normal.<br />
There was history of such a problem in his mother, his mother’s 3<br />
sibling and also grandfather which was presented in higher age and in<br />
their children in lower age.<br />
Case 2:<br />
A 36 years old man with progressive ataxia and tremor which was began<br />
from 6 years before with one apparently normal child, normal mental<br />
state, disturbed cerebellar exam including progressive ataxic gait,<br />
dysartheria, intention and postural tremor, dysmetria, dysdiadokinesis<br />
was seen in exam. Brain MRI showed cerebellar atrophy.<br />
There was some history of such a problem in his father, sib line and<br />
also in pedigree<br />
Diagnosis:<br />
Extracted DNA was investigated for the GAA expansion repeat in the<br />
FRDA gene and SCA types including 1,2,3,6,7.<br />
The two probands showed abnormal pattern for SCA 7 and SCA 2<br />
respectively.<br />
P0236. Juvenile and young adults SCA1 patients in Poland -<br />
genetic and clinical features.<br />
E. Zdzienicka, M. Rakowicz, R. Rola, A. Sulek-Piatkowska, T. Jakubowska, W.<br />
Szirkowiec, R. Poniatowska, U. Zalewska, J. Zaremba, E. Bertrand;<br />
Institute of Psychiatry and Neurology, Warsaw, Poland.<br />
Spinocerebellar ataxia type 1 (SCA1) is the most common form of<br />
ADCA in Poland. The phenotype and age at disease onset are highly<br />
variable. The aim of the study was to investigate the influence of the<br />
transmission pattern on genetic and clinical features of juvenile SCA1<br />
patients.<br />
Methods: 125 SCA1 patients from 101 families were analysed retrospectively.<br />
The mean age at onset was 35.6 +/- 9.6 and the average<br />
CAG repeats in affected family members was 50.7 +/- 5.5, ranging<br />
from 42 to 72. Paternal and maternal transmission was equal. In 21<br />
SCA1 families with 25 juvenile patients, the relation of clinical severity,<br />
sex, CAG repeats number and age at disease onset of transmitting<br />
parents was analysed. The International Cooperative Ataxia Rating<br />
Scale (ICARS), electrophysiological and psychological examinations<br />
were compared in regard to transmission pattern.<br />
Results: In 14 cases with paternal and in 11 patients with maternal<br />
transmission the mean age at onset 20.5 +/-3.6 y. (range 12 - 25 y.),<br />
disease duration 6.3 +/-3.7 y. and the CAG repeats number, mean<br />
58.0 +/- 5.7 were not different. However, mean age at onset of fathers<br />
was 33.0 y. and of mothers 29.1y. Severity of non-cerebellar signs and<br />
ataxia were more pronounced in patients with paternal than with maternal<br />
transmission: ICARS 34.8 and 32.8, Intelligence Quotient 92.9<br />
and 107, respectively.<br />
Conclusions: In our SCA1 patients the anticipation was more prominent<br />
in subjects with paternal than with maternal transmission.<br />
Supported by Polish Ministry of Science grant 3PO5B 0<strong>19</strong> 24, partly by<br />
EUROSCA/LSHM-CT-2004-503304.<br />
P0237. A case of spinocerebellar ataxia type 17 (SCA17)<br />
associated with homozygous 46/47 repeats of the TBP gene<br />
P. Tarantino1 , E. V. De Marco1 , E. Pisano2 , F. Annesi1 , F. E. Rocca1 , D. Civitelli1 ,<br />
I. C. Cirò Candiano1 , S. Carrideo1 , G. Provenzano1 , V. Greco1 , G. Squillace1 , M.<br />
Caracciolo1 , G. Annesi1 ;<br />
1 2 Institute of Neurological Sciences, Mangone (Cosenza), Italy, Department of<br />
Neurology Hospital Cosenza, Cosenza, Italy.<br />
Spinocerebellar ataxia type 17 (SCA17) is a dominant progressive<br />
neurodegenerative disorder, caused by a triplet repeat expansion<br />
within the TATA-binding protein gene (TBP); normal expansions range<br />
from 29 to 42 repeats, whereas abnormal expansions range from 43<br />
to 63 repeats. A reduced penetrance is associated to 43-48 repeats.<br />
The disease is characterized by progressive limb and gait ataxia, dys-<br />
arthria, motor, cognitive and psychiatric abnormalities.<br />
In this study, we describe a SCA patient from Southern Italy with ataxia,<br />
pyramidal and extrapyramidal signs and peripheral neuropathy.<br />
We investigated this patient for CAG repeat expansions in the genes of<br />
the spinocerebellar ataxias SCA1, SCA2, SCA3 SCA6, SCA7, SCA8,<br />
SCA12, SCA17 and DRPLA.<br />
Genomic DNA was amplified with fluorescent primers spanning the<br />
SCA expansions. PCR products were separated onto a capillary sequencer<br />
(3130XL genetic analyzer-Applied Biosystems) and the length<br />
of specific SCA fragments was calculated referring to a size standard<br />
and to related SCA controls. We identified an abnormal CAG/CAA repeat<br />
expansion of 46/47 size, within the TBP gene, confirmed by direct<br />
sequencing of the expanded SCA17 alleles showing the following structure:<br />
(CAG)3 (CAA)3(CAG)9CAACAGCAA(CAG)26/27CAACAG.<br />
This is the second case of homozygous expansion reported in a patient<br />
with SCA17. Currently, genetic and clinical analysis of other family<br />
members are ongoing to evaluate the genotype-phenotype correlation<br />
in this family.<br />
P0238. Identification of genomic dosage variation of CNTNAP2<br />
in patients with schizophrenia and epilepsy<br />
T. Vrijenhoek;<br />
Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands.<br />
Contactin-associated protein-like 2 (Caspr2) clusters voltage-gated<br />
potassium channels (K v1.1) at the nodes of Ranvier and is encoded<br />
by CNTNAP2 - the largest gene in the human genome. Homozygous<br />
stop mutations in exon 22 of this gene were recently identified in Old<br />
Order Amish children with cortical dysplasia, focal epilepsy, relative<br />
macrocephaly, and diminished deep-tendon reflexes. We identified<br />
deletions affecting (part of) CNTNAP2 in three patients by routine<br />
chromosome analysis and microarray-based genomic copy number<br />
analysis methods.<br />
A deletion covering the chromosomal region 7q34-7q36.1 was revealed<br />
in one severely mentally retarded epilepsy patient by routine<br />
chromosome analysis, and shown to be de novo by Fluorescent In-<br />
Situ Hybridisation (FISH) analysis. The deletion was 10.7 Mb in size,<br />
affecting 58 genes including CNTNAP2. A second deletion was identified<br />
by array-based Comparative Genomic Hybridisation (arrayCGH)<br />
in a patient suffering from both epilepsy and schizophrenia. This deletion<br />
of 1.5 Mb was confirmed by Multiplex Logation-dependent Probe<br />
Amplification (MLPA), and also affected CNTNAP2. To study the link<br />
between schizophrenia and CNTNAP2 further, we developed a targeted<br />
Single Nucleotide Polymorphism (SNP) array for this gene and its<br />
surrounding genomic region. Out of 315 patients and an equal number<br />
of controls, we identified a deletion in intron 3 of CNTNAP2 in a third<br />
schizophrenic patient, which also has a history of epilepsy.<br />
Together these results confirm that CNTNAP2 is associated with epilepsy,<br />
but they also show that genomic rearrangements resulting in<br />
haploinsufficiency of CNTNAP2 may lead to a more complex phenotype<br />
that also includes schizophrenia.<br />
P0239. A Case of Seckel Syndrome conceived by Assisted<br />
Reproductive Technology<br />
N. Andıran1 , E. Tuncbilek2 , E. Odemıs1 , D. Aktas2 ;<br />
1 2 Fatih University, Department of Pediatrics, Ankara, Turkey, Hacettepe University<br />
School of Medicine, Department of <strong>Genetics</strong>, Ankara, Turkey.<br />
Seckel syndrome is a rare autosomal recessive disorder characterized<br />
by severe pre- and postnatal growth retardation, microcephaly, mental<br />
retardation and typical facial appearance. It has also been called “birdheaded<br />
dwarfism”. Related with Seckel syndrome, three loci have been<br />
mapped and to date the only causative mutation has been observed<br />
as a hypomorphic mutation in Ataxia telengiectasia and Rad3-related<br />
(ATR) gene. Although assisted reproductive technologies (ART) including<br />
in vitro fertilization (IVF) and intracytoplasmic sperm injection<br />
(ICSI) are generally considered safe, some studies have suggested an<br />
excess occurrence of birth defects and low birth-weight. Recently, various<br />
syndromes involving epigenetic alterations have been reported to<br />
occur in individuals following ART. Here we report a patient with Seckel<br />
Syndrome conceived by ICSI. To the best of our knowledge, Seckel<br />
syndrome has not been reported in patients conceived by ART and we<br />
think that epigenetic mechanisms may be related with this syndrome<br />
in our patient.